Urethral Bulking in the Treatment of Stress and Mixed Female Urinary Incontinence: Results from a Multicenter Cohort and Predictors of Clinical Outcomes
Authors:
- Alessandro GiammòAGAlessandro Giammò
- Paolo GerettoPGPaolo Geretto
- Enrico AmmiratiEAEnrico Ammirati
- Alberto ManasseroAMAlberto Manassero
- Luisella SquintoneLSLuisella Squintone
- Marco FalconeMFMarco Falcone
- Elisabetta CostantiniECElisabetta Costantini
- Giulio Del PopoloGPGiulio Del Popolo
- Enrico Finazzi AgròEAEnrico Finazzi Agrò
- Antonella GiannantoniAntonella Giannantoni
- Vincenzo Li MarziVincenzo Li Marzi
- Vito ManciniVMVito Mancini
Open Access
- 12 March 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (6) , 1569
Abstract
The aim of the present study is to analyze the outcomes of urethral bulking in the treatment of non-neurogenic female stress and mixed urinary incontinence and to assess predictors of clinical outcomes. We retrospectively included all consecutive patients affected by stress or mixed urinary incontinence and treated with urethral bulking. Outcomes were evaluated via the PGI-I questionnaire and the 24-h pad test. Between January 2010 and January 2020, we treated 216 patients (Bulkamid n = 206; Macro-plastique n = 10). The median age at surgery was 66 years (IQR 55–73.75). The median follow-up was 12 months (IQR 12–24). In total, 23.8% of patients were subjected to prior incontinence surgery, 63.8% of patients were affected by genuine stress urinary incontinence, 36.2% reported mixed urinary incontinence, whereas detrusor overactivity was confirmed in only 24.9%. The dry rate was 32.9%; nevertheless, 69.9% of patients declared themselves “very improved” or “improved” (PGI-I1-2). Low complications were observed, mostly classified as Clavien I. After univariate and multivariate analyses, the only statistically significant independent predictor of “dry” outcome was the 24 h pad test, p < 0.001. Urethral bulking could be proposed with more expectations of success in patients with mild urinary incontinence. Patients affected by moderate–severe incontinence are less likely to obtain clinical success; therefore, they should be carefully counselled about clinical expectations before the procedure.Keywords
This publication has 16 references indexed in Scilit:
- An analysis of 1386 periurethral bulking procedures with comparison to 18,763 retropubic tapesPost Reproductive Health, 2020
- Urethral bulking with Bulkamid: An analysis of efficacy, safety profile, and predictors of functional outcomes in a single‐center cohortNeurourology and Urodynamics, 2020
- Patient Characteristics that May Influence the Effect of Urethral Injection Therapy for Female Stress Urinary IncontinenceJournal of Urology, 2019
- Efficacy and safety of polydimethylsiloxane injection (Macroplastique ® ) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow‐upBJU International, 2018
- Urethral injection therapy for urinary incontinence in womenCochrane Database of Systematic Reviews, 2017
- Para-Urethral Injections with Urolastic® for Treatment of Female Stress Urinary Incontinence: Subjective Improvement and SafetyUrologia Internationalis, 2017
- Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trialBJOG: An International Journal of Obstetrics & Gynaecology, 2005
- Validation of two global impression questionnaires for incontinenceAmerican Journal of Obstetrics and Gynecology, 2003
- The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence SocietyUrology, 2003
- Perineal pad test in evaluating outcome of treatments for female incontinence: a systematic review.2002